AAAAAA
Results:
1-17
|
Results: 17
Authors:
Withoff, S
Glazenburg, KL
van Veen, ML
Kraak, MMJ
Hospers, GAP
Storkel, S
de Vries, EGE
Wischut, J
Daemen, T
Citation: S. Withoff et al., Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines, GENE THER, 8(20), 2001, pp. 1515-1523
Authors:
Reutzel, D
Mende, M
Naumann, S
Storkel, S
Brenner, W
Zabel, B
Decker, J
Citation: D. Reutzel et al., Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization, CYTOG C GEN, 93(3-4), 2001, pp. 221-227
Authors:
Poulakis, V
Witzsch, U
de Vries, R
Becht, E
Altmannsberger, HM
Storkel, S
Citation: V. Poulakis et al., Alpha-fetoprotein-producing renal cell carcinoma, UROL INTERN, 67(2), 2001, pp. 181-183
Authors:
Velickovic, M
Delahunt, B
Storkel, S
Grebe, SKG
Citation: M. Velickovic et al., VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance, CANCER RES, 61(12), 2001, pp. 4815-4819
Authors:
Seliger, B
Rongcun, Y
Atkins, D
Hammers, S
Huber, C
Storkel, S
Kiessling, R
Citation: B. Seliger et al., HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes, INT J CANC, 87(3), 2000, pp. 349-359
Authors:
Maeurer, MJ
Trinder, P
Hommel, G
Walter, W
Freitag, K
Atkins, D
Storkel, S
Citation: Mj. Maeurer et al., Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice, INFEC IMMUN, 68(5), 2000, pp. 2962-2970
Authors:
Brauch, H
Weirich, G
Brieger, J
Glavac, D
Rodl, H
Eichinger, M
Feurer, M
Weidt, E
Puranakanitstha, C
Neuhaus, C
Pomer, S
Brenner, W
Schirmacher, P
Storkel, S
Rotter, M
Masera, A
Gugeler, N
Decker, HJ
Citation: H. Brauch et al., VHL alterations in human clear cell renal cell carcinoma: Association withadvanced tumor stage and a novel hot spot mutation, CANCER RES, 60(7), 2000, pp. 1942-1948
Authors:
Brauch, H
Weirich, G
Hornauer, MA
Storkel, S
Wohl, T
Bruning, T
Citation: H. Brauch et al., Trichloroethylene exposure and specific somatic mutations in patients withrenal cell carcinoma, J NAT CANC, 91(10), 1999, pp. 854-861
Authors:
Filipas, N
Fisch, M
Fichtner, J
Fitzpatrick, J
Berg, K
Storkel, S
Hohenfellner, R
Thuroff, JW
Citation: N. Filipas et al., The histology and immunohistochemistry of free buccal mucosa and full-skingrafts after exposure to urine, BJU INT, 84(1), 1999, pp. 108-111
Authors:
Schaub, TP
Kartenbeck, J
Konig, J
Spring, H
Dorsam, J
Staehler, G
Storkel, S
Thon, WF
Keppler, D
Citation: Tp. Schaub et al., Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma, J AM S NEPH, 10(6), 1999, pp. 1159-1169
Authors:
Brieger, J
Weidt, EJ
Schirmacher, P
Storkel, S
Huber, C
Decker, HJ
Citation: J. Brieger et al., Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors, J MOL MED-J, 77(6), 1999, pp. 505-510
Authors:
Gronwald, J
Hadaczek, P
Storkel, S
Holtgreve-Grez, H
Rabbitts, P
Cremer, T
Lubinski, J
Citation: J. Gronwald et al., Molecular evidence for derivation of metastatic cells from minor subclonesof primary clear renal cell carcinomas, CANCER DET, 23(6), 1999, pp. 479-484
Authors:
Storkel, S
Citation: S. Storkel, Epithelial tumors of the kidney, pathological subtyping and cytogenetic correlation, UROLOGE, 38(5), 1999, pp. 425-432
Authors:
Perot, C
Bougaran, J
Boccon-Gibod, L
Storkel, S
Leverger, G
van den Akker, J
Taillemite, JL
Couturier, J
Citation: C. Perot et al., Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females, CANC GENET, 110(1), 1999, pp. 54-56
Authors:
Schwerdtle, RF
Storkel, S
Neuhaus, C
Brauch, H
Weidt, E
Brenner, W
Hohenfellner, R
Huber, C
Decker, HJ
Storkel, S
Brauch, H
Citation: Rf. Schwerdtle et al., Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, 21q significantlycorrelate with the chromophobe subtype of renal cell carcinoma. (vol 56, pg 2927, 1996), CANCER RES, 59(8), 1999, pp. 2021-2021
Authors:
Schwerdtle, RF
Winterpacht, A
Storkel, S
Brenner, W
Hohenfellner, R
Zabel, B
Huber, C
Decker, HJ
Storkel, S
Brauch, H
Citation: Rf. Schwerdtle et al., Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. (vol 57, pg 5009, 1997), CANCER RES, 59(8), 1999, pp. 2021-2021
Authors:
Kollias, A
Poulakis, V
Witzsch, U
Becht, E
Storkel, S
Citation: A. Kollias et al., Alpha-fetoprotein-producing renal cell carcinoma, AKT UROL, 30(3), 1999, pp. 199-203
Risultati:
1-17
|